Stonegate Investment Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$242K Buy
748
+223
+42% +$69.4K 0.01% 359
2025
Q2
$204K Buy
525
+63
+14% +$25.3K 0.01% 384
2025
Q1
$201K Buy
+462
New +$185K 0.01% 346
2024
Q4
Sell
-456
Closed -$237K 409
2024
Q3
$237K Buy
+456
New +$244K 0.01% 313

Other funds holding ELV

Stonegate Investment Group's ELV Position: Q3 2025 in Review

Stonegate Investment Group increased its Elevance Health (ELV) stake by 42% in Q3 2025, buying an estimated $69.4K and bringing the position to 748 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #359.

Stonegate Investment Group first reported a position in ELV in Q3 2024 and has held it in 4 quarters since. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Stonegate Investment Group held 748 shares of Elevance Health worth $242K as of Q3 2025.
  • Stonegate Investment Group bought 223 Elevance Health shares in Q3 2025, an estimated $69.4K.
  • Elevance Health made up 0.01% of Stonegate Investment Group's portfolio in Q3 2025, its #359 holding.
  • Stonegate Investment Group first reported a position in Elevance Health in Q3 2024 and has held it in 4 quarters since.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.